Guidance on how to get an e-cigarette on the market in Great Britain and Northern Ireland, including the notification scheme and reporting problems with e-cigarettes.
The MHRA is the competent authority for a notification scheme for e-cigarettes and refill containers in Great Britain and Northern Ireland and is responsible for implementing the majority of provisions under Part 6 of the Tobacco and related Products Regulations (TRPR) and the Tobacco Products and Nicotine Inhaling Products (Amendment) (EU Exit) Regulations 2020.
The TRPR introduced rules which ensure:
minimum standards for the safety and quality of all e-cigarettes and refill containers (otherwise known as e-liquids)
that information is provided to consumers so that they can make informed choices
an environment that protects children from starting to use these products.
restrict e-cigarette tanks to a capacity of no more than 2ml
restrict the maximum volume of nicotine-containing e-liquid for sale in one refill container to 10ml
restrict e-liquids to a nicotine strength of no more than 20mg/ml
require nicotine-containing products or their packaging to be child-resistant and tamper evident
ban certain ingredients including colourings, caffeine and taurine
include new labelling requirements and warnings
require all e-cigarettes and e-liquids be notified to the MHRA before they can be sold
The Tobacco Products and Nicotine Inhaling Products (Amendment) (EU Exit) Regulations 2020 is available here:
An Explanatory Memorandum explains the changes from a policy perspective:
The 2020 regulations amend the Tobacco Products and Nicotine Inhaling Products (Amendment etc) (EU Exit) Regulations 2019 to implement the obligations of the Withdrawal Agreement and the Northern Ireland Protocol in law. This amends the way in which the Tobacco and Related Products Regulations 2016 apply in Great Britain and Northern Ireland
The 2020 Regulations sets out the requirements for new products to be notified from 1 January 2021. This will mean that:
Producers placing products on the Northern Ireland market will be required to notify using the EU Common Entry Gate (EU-CEG) system for the notification of tobacco and e-cigarette products.
Producers placing products on the Great Britain market will be required to notify on the Great Britain domestic system.
Notifiers will be required to pay one fee if they notify in relation to placing products on one of the Great Britain or Northern Ireland markets and the same one fee if they notify in relation to placing products on the two markets.
A producer is anyone who manufactures or imports these products or who re-brands any product as their own.
Retailers do not need to submit information for any products they sell unless they also qualify as a producer.
The Tobacco and Related Products Regulations 2016 do not cover nicotine-containing products that are authorised as medicines. Further information about licensing these products as medicines can be found here.
Advice for consumers
Reporting an adverse reaction via Yellow Card
If you feel unwell after using an e-cigarettes product you can report side effects and safety concerns with e-cigarettes or refill containers to the MHRA through the Yellow Card scheme.
If you would like to provide information about the sale of defective, non-compliant or illegal e-cigarette products you can contact the MHRA at TPDsafety@mhra.gov.uk, alternatively you can contact Trading Standards.
Yellow Card reports submitted to the MHRA are added to our vigilance database where reports are looked at by our specialist team of assessors. Reports are assessed for potential patterns of concern by our team of scientists, doctors and pharmacists. Should any potential safety concerns be identified the MHRA are able to take regulatory action to safeguard the public.
Data from Yellow Card reports received relating to suspected side effects to nicotine-containing e-cigarettes can be viewed on the accompanying guidance document explaining how this data should be interpreted.. It is important to note that inclusion of a report of the Analysis Print does not necessarily mean that the effect was caused by the e-cigarette just that there was a suspicion it might have been. Please see
The e-cigarette Analysis Profile contains data for all spontaneous suspected adverse reactions, or side effects, which have been reported to the MHRA, via the Yellow Card scheme from healthcare professionals and members of the public involving a nicotine-containing e-cigarette. Only adverse reaction reports to nicotine-containing e-cigarettes appear on the Analysis Profile, reports of other product safety or quality concerns associated with e-cigarettes are shared with local Trading Standards officers and Public Health England as appropriate.
Notified products for Great Britain and Northern Ireland
Producers must submit information about their products to the MHRA through the MHRA Submission Portal and European Common Entry Gate (EU-CEG) notification portal for UK wide supply.
From 23 August, products which have been successfully notified via MHRA Submissions will be published directly on the MHRA publication home page. Selecting the “ECIG” tile will provide direct access to the GB notified products list, published since 1 January 2021. You will be able to view this information using the following searches:
- Submitter Name
- Brand Name
- Brand Sub Type
- Product Type
A link below the search boxes on this page will provide access to:
- UK Products published up to 31 December 2020
- Products published for Northern Ireland from 1 January 2021
- Withdrawn Products
Products are not compliant for supply until the notification has been published on the relevant list for Great Britain and/or Northern Ireland.
Advice for retailers
When sourcing new supplies of any e-cigarette or e-liquid product, check that a compliant notification has been published in one of the Notified Product lists above.
If you cannot find the product on the MHRA’s website, ask your supplier to confirm that it has been published and provide details to enable you to confirm the products status. If a product has yet to achieve publication status, they may not supply it to you.
See our advice for retailers setting out the key requirements (PDF, 118KB, 2 pages)
The TRPR requirements on nicotine concentration (20mg/ml maximum) and size of presentation (10ml maximum for refill container and 2ml maximum for e-cigarettes) apply to products sold to end consumers (irrespective of whether the end consumer intends to modify the product).
Are you also a producer?
As a retailer, you do not need to notify any products you sell unless you are also a ‘producer’ of the product.
A producer is anyone who manufactures or imports e-cigarette or refill container products and anyone who re-brands them as their own. If you qualify as a producer, please see the guidance below for putting a new product onto the UK market.
If you import or re-brand products, check with your supplier whether they have already made a UK notification for the specific product you sell. If they have done so, you do not need to submit a duplicate notification.
Cross border sales
The requirement for retailers to register for cross-border distance sales (CBDS) in Great Britain and Northern Ireland has changed following the end of the transition period.
The requirement to register for CBDS into and out of Northern Ireland will be the same. However, the requirement to register for CBDS into and out of Great Britain (England, Scotland and Wales) is removed. This is set out in the new [Tobacco Products and Nicotine Inhaling Products (Amendment) (EU Exit) Regulations 2020((https://www.legislation.gov.uk/uksi/2020/1316/contents/made).
Updated guidance on the registration requirements for CBDS of tobacco products and electronic cigarettes (including e-liquids, devices and components) to consumers in Great Britain, Northern Ireland, European Union member states or a third country, is available at Tobacco products and e-cigarette cross-border sales: registration.
The UK government will publish registrations that are compliant with the new regulations. Retailers’ trading name and website addresse(s) will be published.
New registrations requests that are not compliant with the new regulations will be rejected and not published.
The current list of published retailers undertaking CBDS to the Great Britain and Northern Ireland will be reviewed and updated for compliancy to the new regulations. Where a registration is found to be non-compliant it will be removed from the published list and the retailer informed by email.
Contact PHE at CBS.Tobacco@phe.gov.uk if you have any queries on the above.
Advice for producers
Putting a new product into the UK market (Great Britain and Northern Ireland)
Producers of new e-cigarette and refill container products must submit a notification to the MHRA six months before they intend to put their product on the market in Great Britain and/or Northern Ireland. Once your notification has been published on our website you can launch the product in the notified region. If your notification has been published, you do not need to wait for the remainder of the 6 month period to elapse before you place your product on the market in the notified region.
Note: Supplying a product to the UK market will require separate notifications for a product via EUCEG (Northern Ireland) and the MHRA submission portal (Great Britain).
A product which has been substantially modified will count as a new product and must also follow this process. Further information regarding what qualifies as a substantial modification can be found in the guidance on submission type below.
If the manufacturer has submitted both a Great Britain and Northern Ireland notification for the specific product you import, then you do not need to submit a duplicate notification. Similarly, if the manufacturer has notified details of a product that you have re-branded, and your brand name is listed in the manufacturer’s notification, then you do not need to submit a duplicate notification.
If you make your product available in Great Britain and Northern Ireland under several brand names, you will be able to include all the brand names for the identical products in a single notification in each region, for no additional fee. Each brand must be listed on the notification as a separate presentation and may not be supplied in Great Britain and Northern Ireland until published on the relevant list for that region.
The TRPR does not include any requirements as to where testing of e-cigarettes and refill containers has to take place. The notifier will need to be satisfied as to the standards of any testing carried out as they have to submit a declaration that they bear full responsibility for the quality and safety of the product when placed on the market and used under normal or reasonably foreseeable conditions.
Other requirements for e-cigarettes
Replacement e-cigarette parts that could contain nicotine only require notification if they have not already been notified as part of a device or e-cigarette kit. Identical replacement parts that have already been notified as part of another notified e-cigarette product do not need to be separately re-notified if it is clear on the labelling what notified product the part is for. Any non-identical replacement part, particularly one that alters the consumer safety profile of a product (for example by changing its refill capacity), would require a separate notification.
Rebuildable devices come within the definition above and require notification. See the product type guidance for further advice.
Manufacturers, Importers and Distributers of e-cigarettes also need to comply with the Restriction of Hazardous Substances in Electrical and Electronic Equipment Regulation 2012 (known as RoHS). These regulations limit the amount of certain hazardous substances in specific electrical equipment, of which e-cigarettes are included. They place obligations onto Manufacturers, Importers and Distributers of e-cigarette models. Details can be found here. The regulation is enforced by the Office for Product Safety and Standards, part of the Department for Business, Energy and Industrial Strategy.
Guidance on the submission and content of notifications for Great Britain
Before getting started
Registering to make submissions to the MHRA provides guidance on how to use MHRA Submissions, including for e-cigarette information.
Ensure that you have watched the videos and have referred to the user reference guides prior to clicking on the link in the Getting Started section.
Three short video demos are provided below which cover all aspects of the user access management process - these steps will enable your organisation to gain access and manage user permissions for using MHRA Submissions. You can access all three videos on Sharefile.
User registration – the end to end process for adding an initial company administrator
Add a new user – how to add an internal colleague as a user or company administrator
Add a new external user – how to add a third party consultant/consultancy as a user or company administrator
There are two user reference guides which contain step by step guidance on the processes:
User Reference Guide – Gaining Access to MHRA Submissions
User Reference Guide – Managing users on MHRA Submissions
Once you have an MHRA Submission Portal account, you can continue with the application process. The MHRA have published guidance to help you with this:
If the MHRA submission portal is providing an option to generate new submitter ID instead of pre-populating your EU submitter ID please report this to the MHRA via the ‘Help and Support’ tile on MHRA submission portal before completing any submissions.
Once you have validated the submitter ID assigned by the MHRA submission portal and it is in line with your EU submitter ID you will have an option to raise a request to update your company display name. A request can be raised via the ‘Help and Support’ tile.
NOTE- Company name displayed on the MHRA submission portal is also used in the extract published on our MHRA gov website.
If your company ownership has changed and you require a new company ID on the MHRA submission portal then you can raise a ticket via the ‘Help and Support’ tile for a change of ownership.
Please note that the MHRA does not provide an XML creator. Notifications to the MHRA can be provided via existing XML documents or manually using our bulk uploader or online form.
To receive fee reduction for both Northern Ireland and Great Britain products must retain the same ECID in both regions. The regulations enable submitters to pay a single fee for Great Britain and Northern Ireland. Changes to the ECID between regions will result in two unique product identifiers which will be charged accordingly.
If you have any difficulties, please contact the portal’s technical team directly via the email addresses below:
- Should you encounter technical difficulties, please contact firstname.lastname@example.org (including in your message a ‘print screen’ of the window where the problem appears)
The format and content of notifications will remain in line with those set out in the Commission Implementing Decision (EU) 2015/2183 on e-cigarettes.
Details of the information notifications are required to contain are set out by the Commission in the Data Dictionary (PDF, 888KB, 37 pages).
We have published below guidance to aid producers of e-cigarettes and refill containers to prepare notifications for their products.
Product type guidance Great Britain (PDF, 168KB, 3 pages)
Submission type guidance Great Britain (PDF, 412KB, 3 pages)
Emissions testing guidance Great Britain (PDF, 93.9KB, 3 pages)
Nicotine dose guidance Great Britain (PDF, 74.2KB, 2 pages)
Ingredient guidance Great Britain (PDF, 265KB, 3 pages)
Labelling guidance Great Britain (PDF, 85.2KB, 2 pages)
Product presentation guidance Great Britain (PDF, 41.2KB, 4 pages)
Annual reporting guidance Great Britain (PDF, 35.9KB, 3 pages)
If you make your product available in Great Britain under several brand names, you will be able to include all the brand names for the identical products in a single notification, for no additional fee. Each brand should be listed on the notification as a separate presentation.
Guidance on the submission and content of notifications for Northern Ireland
The format and content of notifications are set out in the Commission Implementing Decision (EU) 2015/2183 on e-cigarettes.
Details of the information notifications are required to contain are set out by the Commission in the Data Dictionary (PDF, 888KB, 37 pages).
Technical requirements for refill mechanisms, and information that must be included in the instructions for use of the product are set out in the Commission Implementing Decision (EU) 2016/586 of 14 April 2016 on technical standards for the refill mechanism of electronic cigarettes.
We have published below guidance to aid producers of e-cigarettes and refill containers to prepare notifications for their products. This guidance has been developed by the UK regulators and other member states and discussed at the European Commission Working Group on notification of e-cigarettes and refill containers.
Product type guidance Northern Ireland (PDF, 168KB, 3 pages)
Submission type guidance Northern Ireland (PDF, 412KB, 3 pages)
Emissions testing guidance North Ireland (PDF, 93.9KB, 3 pages)
Nicotine dose guidance Northern Ireland (PDF, 74.2KB, 2 pages)
UK ingredient guidance Northern Ireland (PDF, 265KB, 3 pages)
Labelling guidance Northern Ireland (PDF, 85.2KB, 2 pages)
Product presentation guidance Northern Ireland (PDF, 41.2KB, 4 pages)
General advice on due diligence Northern Ireland (PDF, 42.5KB, 2 pages)
The fees for submitting a notification are a set out in The Electronic Cigarettes etc. (Fees) Regulations 2016. The MHRA consulted on the level of these fees in January 2016 and the Government Response to the consultation can be found here.
The current costs of notifications are as follows:
Notification fee: £150 (Per ECID notified in both Great Britain and Northern Ireland)
Annual and Substantial Modification fees will be reviewed in 2021
The MHRA has given a commitment to review the level of fees in the light of the number of notifications received each year.
Payments via MHRA Submissions
From 23 August 2021 submitters are required to pay for notifications using the integrated system provided as part of MHRA Submissions. Upon validation of a submission you will be able download your invoice and pay for notifications via MHRA Submissions. This payment will cover the cost of the notification for Great Britain and Northern Ireland, if it has been submitted via MHRA Submissions and EUCEG.
Payments for GB submissions must be completed using the MHRA Submission Portal payment option.
If you do not want to submit the notification for assessment or require another company employee to make payments for the submission you will be able to save the draft and complete the submission and payment at a later time.
Please be aware that our assessment team will not have access to your submissions for review until payment has been completed via MHRA Submissions.
If you only intend to market your product in Northern Ireland you can continue to use the current service and will receive invoices which can be paid online using a debit or credit card. GB submissions cannot be processed using this payment system.
We accept all major debit and credit cards including Visa, Mastercard, Maestro and American Express. Payments can be made in British Pounds Sterling only
Once the product has been reviewed and published by the MHRA it is legal for supply to the relevant region If you have not received an invoice, or have any queries please contact the MHRA Accounts Receivable team at email@example.com.
The definitions of products that are subject to the regulations are set out below.
‘Electronic cigarette’ means a product that can be used for consumption of nicotine-containing vapour via a mouth piece, or any component of that product, including a cartridge, a tank and the device without cartridge or tank. E-cigarettes can be disposable or refillable by means of a refill container and a tank, or rechargeable with single use cartridges.
Products that require a notification are limited to the e-cigarette product and component elements sold separately that specifically contain, or could contain, nicotine in the form of e-liquid. Therefore e-cigarette products such as disposable units and tanks will require a notification; however e-cigarette equipment such as mouthpieces, batteries and other elements that would qualify as an individual component will not.
Products that do not meet the definition (such as disposable e-cigarettes that do not contain nicotine and 0% nicotine e-liquids) are out of scope of the TRPR and do not have to meet its requirements. These products will continue to be regulated under the General Product Safety Regulations.
The requirements do not apply to ‘trade sales’, for example where you are selling industrial quantities of nicotine-containing liquid (typically over 25 litres) to another business and the sale is not directed to a consumer. But for all sales (trade and to consumers) the tank capacity of a refillable e-cigarette must not exceed 2ml.The capacity of refill containers must not exceed 10 ml with a maximum nicotine concentration of 20mg.
‘Producers’ refers to any manufacturer; importer and/or those who re-brand any of the products covered by the above definitions as their own.
Extender and replacement tanks cannot be supplied in the UK if they are above 2ml capacity, as they do not meet the requirements of the regulations. Non-compliant extender/replacement tanks may not be supplied as part of a notified product/kit for sale.
Products that feature non-essential components that alter maximum tank size, such as plastic plugs and bungs do not meet the requirement of the regulations and are considered non-compliant for UK supply.
Squonkers do not meet the requirements of the regulations if supplied with a squonk bottle/ reservoir or tank by any other name with a capacity above 2ml. Any containers supplied with a squonker must comply with the regulations and therefore cannot be supplied if the capacity exceeds 2ml. Any refill containers supplied with a squonker must comply with the regulations.
Notified compliant products cannot be packaged with non-compliant accessories for supply in the UK market. Producers supplying any of the products listed above should take immediate corrective action and may be required to provide the following information.
Evidence that the product is available in compliant format or packaging for in Great Britain and Northern Ireland supply
Evidence of corrective action taken to remove or bring the presentation of the product into compliance for the UK market
‘Refill container’ means a receptacle that holds a nicotine-containing liquid, which can be used to refill an electronic cigarette. These are more commonly known as e-liquids.
Cannabidiol (CBD) Vape Products in nicotine containing refill containers are likely to create the impression that the product has a health benefit, and therefore, is an additive subject to prohibition under regulations 16(1)(a) of the Regulations. Regulation 16(1)(a) prohibits the use of “vitamins or other additives that create the impression that a tobacco product has a health benefit”. This opinion is consistent with the prohibitions on other additives under the Regulations and is not a statement of CBD’s safety for use in consumer products.
Reporting safety concerns
E-cigarette producers must inform the MHRA if they have reason to believe that a notifiable product is unsafe, not of good quality or not compliant with TRPR regulations and provide details of the risk to human health and safety and any corrective action taken. E-cigarette producers should notify the MHRA by email to TPDsafety@mhra.gov.uk.
Trading Standards bodies have enforcement responsibilities under the legislation and the MHRA works with them to ensure acceptable standards of safety.
Labelling and leaflets
Regulation 37 of the Tobacco and Related Products Regulations 2016 sets out the requirements for labelling of e-cigarette and refill container products.
All ingredients in the product should be listed on the label where they are used in quantities of 0.1% or more of the final formulation of the e-liquid. Where a flavour ingredient contains several component chemicals, we consider that it is acceptable to describe the ingredient on the label by the name of the flavour, for example ‘strawberry flavour’. For confidentiality reasons companies may choose to describe individual ingredients used in quantities below 0.1% of the final formulation by category, for example ‘other flavourings’.
This advice only applies to product labels, and a full list of ingredients in the flavouring must be included in notifications through the EU-CEG.
The TRPR also requires that packs include an information leaflet about safe use of the product. We encourage you to ensure your leaflets include appropriate advice on product storage, particularly on how to ensure the battery does not malfunction.
Where all the required leaflet information can fit on the unit pack and other labelling within the pack without loss of legibility to the consumer, our interpretation of the TPD is that the packaging can be considered to include the leaflet, and a separate leaflet insert is not required.
Additional statutory labelling requirements may also apply, such as the European Regulation (EC) No 1272/2008 on classification, labelling and packaging of chemical substances (CLP). Information on CLP requirements is available from the ECHA website and the HSE website. Additional advice is available from the UK CLP Helpdesk at UKREACHCA@hse.gov.uk.
If your e-cigarette product does not contain nicotine when sold, but can be used to contain nicotine, the warning statement ‘this product contains nicotine which is a highly addictive substance’ must still be applied. To provide clarity for consumers, we recommend adjacent wording (not part of the boxed warning) to the effect that the warning applies when the product is used as designed and charged / filled with nicotine-containing liquid. The warning statement should be included on all notified e-cigarette producer.
Sources of further information
European Commission pages on tobacco policy – for the text of the Tobacco Products Directive and Implementing Acts, notes of Commission meetings, etc.
For more information on the regulatory framework, or to register for ongoing updates about the scheme, TPDnotifications@mhra.gov.uk.
Please note that the MHRA does not run the notification portal or XML creator. If you have any difficulties, please contact the portal’s technical team directly via the email addresses below:
Should you encounter technical difficulties, please contact SANTE-EUCEG-ITSUPPORT@ec.europa.eu (including in your message a ‘print screen’ of the window where the problem appears)
Should you encounter difficulties in obtaining a submitter ID, please contact SANTE-SUBID-EUCEG@ec.europa.eu.
For other general matters related to the functioning of the EU-CEG, but not to your request, please contact SANTE-EU-CEG@ec.europa.eu
We will be updating this page with the latest information, register for updates.